{"filing":{"accession_number":"0001654954-26-007998","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"a7703s.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007998/a7703s.htm"},"events":[{"id":30790,"run_id":28231,"accession_number":"0001654954-26-007998","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"GSK announced positive Phase II data for its mRNA seasonal flu vaccine candidate and disclosed advancement to Phase III trials starting September 2026. This is a material operational/clinical milestone in a significant vaccine development program, reflecting progress in GSK's respiratory vaccines research. The disclosure includes FDA Fast Track designation and comparative immunogenicity data versus licensed vaccines, which would affect a reasonable investor's assessment of GSK's pipeline and competitive position in vaccines.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-09-01","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":33502,"accession_number":"0001654954-26-007998","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"GSK announced positive Phase II data for its mRNA seasonal flu vaccine candidate and disclosed advancement to Phase III trials starting September 2026. This is a material operational/clinical milestone in a significant vaccine development program, reflecting progress in GSK's respiratory vaccines research. The disclosure includes FDA Fast Track designation and comparative immunogenicity data versus licensed vaccines, which would affect a reasonable investor's assessment of GSK's pipeline and competitive position in vaccines.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-01T11:47:37.069395+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-09-01"}]}